Literature DB >> 1370773

Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1.

S J Bell1, D A Cooper, B E Kemp, R R Doherty, R Penny.   

Abstract

The majority of the immunodominant amino acid sequences of HIV-1 that have been characterized to date are coded for by hypervariable gene sequences. These variable sequences are however interspersed with sequences that are highly conserved between HIV strains. Immunogenic viral products with amino acid sequences that vary minimally between strains, and that consistently elicit both humoral and cellular immune responses, may be ideal for inclusion in a subunit vaccine. We studied HIV-seronegative and HIV-infected persons, classified as asymptomatic (AS), ARC or AIDS. Initially, we assessed the cellular immune status of each subject from results of T cell phenotype analyses, assays for serum levels of surrogate markers of disease progression, and responses to mitogens and recall antigen. In addition, we tested whether three short synthetic peptides derived from the conserved sequences of the envelope gp120 (aa 262-284) and gp41 (aa 579-601), and core p17 (aa 106-125) regions of the HTLV-IIIB isolate, could elicit B cell as well as T cell responses in HIV-infected subjects. Only the gp41-derived sequence was immunogenic at both B and T cell levels. To further characterize the gp41 epitope, we used a series of overlapping synthetic peptides derived from a conserved region of the envelope gp41 (aa 572-613). We thus identified an immunodominant 12-mer peptide sequence, gp41(8)(aa 593-604), which consistently elicited both T cell blastogenic and B cell (antibody) responses in AS HIV-seropositive individuals but not in ARC and AIDS patients. Linear regression analysis showed that in AS persons there was a strong positive correlation (P less than 0.0005) between the absolute CD8+ T cell numbers and the magnitude of blastogenic responses to the gp41(8)(aa 593-604). Furthermore, those AS subjects with T cells that proliferated in response to this gp41 analogue also had significantly greater serum levels of antibody to the same short peptide sequence than symptomatic ARC and AIDS patients. These results suggest that cellular responses to the immunodominant and highly conserved envelope sequences of HIV-1, associated with increased CD8+ T cells, may be important in the pathogenesis of HIV disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370773      PMCID: PMC1554222          DOI: 10.1111/j.1365-2249.1992.tb06410.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations.

Authors:  A Meyerhans; R Cheynier; J Albert; M Seth; S Kwok; J Sninsky; L Morfeldt-Månson; B Asjö; S Wain-Hobson
Journal:  Cell       Date:  1989-09-08       Impact factor: 41.582

2.  Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus.

Authors:  R L Willey; R A Rutledge; S Dias; T Folks; T Theodore; C E Buckler; M A Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

3.  Characterization and epitope mapping of a human monoclonal antibody reactive with the envelope glycoprotein of human immunodeficiency virus.

Authors:  B Banapour; K Rosenthal; L Rabin; V Sharma; L Young; J Fernandez; E Engleman; M McGrath; G Reyes; J Lifson
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

4.  Mapping of IgG subclass and T-cell epitopes on HIV proteins by synthetic peptides.

Authors:  T Mathiesen; P A Broliden; J Rosen; B Wahren
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

5.  HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions.

Authors:  M Goodenow; T Huet; W Saurin; S Kwok; J Sninsky; S Wain-Hobson
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

6.  Autologous red cell agglutination assay for HIV-1 antibodies: simplified test with whole blood.

Authors:  B E Kemp; D B Rylatt; P G Bundesen; R R Doherty; D A McPhee; D Stapleton; L E Cottis; K Wilson; M A John; J M Khan
Journal:  Science       Date:  1988-09-09       Impact factor: 47.728

7.  B- and T-lymphocyte responses to an immunodominant epitope of human immunodeficiency virus.

Authors:  R D Schrier; J W Gnann; A J Langlois; K Shriver; J A Nelson; M B Oldstone
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

8.  Genomic diversity of human T-lymphotropic virus type III (HTLV-III).

Authors:  F Wong-Staal; G M Shaw; B H Hahn; S Z Salahuddin; M Popovic; P Markham; R Redfield; R C Gallo
Journal:  Science       Date:  1985-08-23       Impact factor: 47.728

9.  Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1.

Authors:  C L Ruegg; C R Monell; M Strand
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

10.  Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT).

Authors:  G G Jackson; D A Paul; L A Falk; M Rubenis; J C Despotes; D Mack; M Knigge; E E Emeson
Journal:  Ann Intern Med       Date:  1988-02       Impact factor: 25.391

View more
  5 in total

1.  Localization of CD4+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing.

Authors:  S Surman; T D Lockey; K S Slobod; B Jones; J M Riberdy; S W White; P C Doherty; J L Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

2.  The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers.

Authors:  Zaza M Ndhlovu; Eleni Stampouloglou; Kevin Cesa; Orestes Mavrothalassitis; Donna Marie Alvino; Jonathan Z Li; Shannon Wilton; Daniel Karel; Alicja Piechocka-Trocha; Huabiao Chen; Florencia Pereyra; Bruce D Walker
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

3.  Synthetic peptides representing sequences within gp41 of HIV as immunogens for murine T- and B-cell responses.

Authors:  L E Brown; D O White; C Agius; B E Kemp; N Yatzakis; P Poumbourios; D A McPhee; D C Jackson
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

4.  Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens.

Authors:  A D Kelleher; M Roggensack; S Emery; A Carr; M A French; D A Cooper
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

5.  Heterogeneous effects of exogenous IL-2 on HIV-specific cell-mediated immunity (CMI).

Authors:  S J Bell; D A Cooper; B E Kemp; R R Doherty; R Penny
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.